BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37266660)

  • 21. Participation and Yield of a Lung Cancer Screening Program in Hebei, China.
    Liang D; Shi J; Li D; Wu S; Jin J; He Y
    Front Oncol; 2021; 11():795528. PubMed ID: 35083151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumour characteristics of bilateral screen-detected cancers and bilateral interval cancers in women participating at biennial screening mammography.
    van Bommel R; Lameijer JRC; Voogd AC; Nederend J; Louwman MWJ; Setz-Pels W; Strobbe LJ; Tjan-Heijnen VCG; Duijm LE
    Eur J Radiol; 2018 Nov; 108():215-221. PubMed ID: 30396659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative Effectiveness of Digital Breast Tomosynthesis and Mammography in Older Women.
    Upneja A; Long JB; Aminawung JA; Kyanko KA; Kunst N; Xu X; Busch SH; Gross CP; Richman IB
    J Gen Intern Med; 2022 Jun; 37(8):1870-1876. PubMed ID: 34595682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-term outcomes of screening mammography using computer-aided detection: a population-based study of medicare enrollees.
    Fenton JJ; Xing G; Elmore JG; Bang H; Chen SL; Lindfors KK; Baldwin LM
    Ann Intern Med; 2013 Apr; 158(8):580-7. PubMed ID: 23588746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
    Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
    Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up?
    Taplin SH; Ichikawa L; Yood MU; Manos MM; Geiger AM; Weinmann S; Gilbert J; Mouchawar J; Leyden WA; Altaras R; Beverly RK; Casso D; Westbrook EO; Bischoff K; Zapka JG; Barlow WE
    J Natl Cancer Inst; 2004 Oct; 96(20):1518-27. PubMed ID: 15494602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mammography screening in the county of Fyn. November 1993-December 1999.
    Njor SH; Olsen AH; Bellstrøm T; Dyreborg U; Bak M; Axelsson C; Graversen HP; Schwartz W; Lynge E
    APMIS Suppl; 2003; (110):1-33. PubMed ID: 12739252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screen-detected and interval breast cancer after concordant and discordant interpretations in a population based screening program using independent double reading.
    Martiniussen MA; Sagstad S; Larsen M; Larsen ASF; Hovda T; Lee CI; Hofvind S
    Eur Radiol; 2022 Sep; 32(9):5974-5985. PubMed ID: 35364710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast Cancers Detected at Screening MR Imaging and Mammography in Patients at High Risk: Method of Detection Reflects Tumor Histopathologic Results.
    Sung JS; Stamler S; Brooks J; Kaplan J; Huang T; Dershaw DD; Lee CH; Morris EA; Comstock CE
    Radiology; 2016 Sep; 280(3):716-22. PubMed ID: 27097237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Digital mammography screening in Germany: Impact of age and histological subtype on program sensitivity.
    Heidinger O; Heidrich J; Batzler WU; Krieg V; Weigel S; Heindel W; Hense HW
    Breast; 2015 Jun; 24(3):191-6. PubMed ID: 25687106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interval breast cancers in the 'screening with tomosynthesis or standard mammography' (STORM) population-based trial.
    Houssami N; Bernardi D; Caumo F; Brunelli S; Fantò C; Valentini M; Romanucci G; Gentilini MA; Zorzi M; Macaskill P
    Breast; 2018 Apr; 38():150-153. PubMed ID: 29328943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a mammography screening program within the population-based Vorarlberg Health Monitoring & Prevention Program (VHM&PP).
    Nagel G; Oberaigner W; Peter RS; Ulmer H; Concin H
    Cancer Epidemiol; 2015 Dec; 39(6):812-8. PubMed ID: 26651439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Digital compared to screen-film mammography: breast cancer prognostic features in an organized screening program.
    Prummel MV; Done SJ; Muradali D; Majpruz V; Brown P; Jiang H; Shumak RS; Yaffe MJ; Holloway CM; Chiarelli AM
    Breast Cancer Res Treat; 2014 Sep; 147(2):389-99. PubMed ID: 25108740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Participation and cancer detection after reminders versus ordinary invitations in BreastScreen Norway.
    Thy JE; Vigeland E; Larsen M; Hofvind S
    J Med Screen; 2022 Sep; 29(3):178-184. PubMed ID: 35502849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interval Breast Cancer Rates and Tumor Characteristics in the Prospective Population-based Malmö Breast Tomosynthesis Screening Trial.
    Johnson K; Lång K; Ikeda DM; Åkesson A; Andersson I; Zackrisson S
    Radiology; 2021 Jun; 299(3):559-567. PubMed ID: 33825509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.
    Ciatto S; Houssami N; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Macaskill P
    Lancet Oncol; 2013 Jun; 14(7):583-9. PubMed ID: 23623721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of breast cancers detected by screening mammography in Taiwan: a single institute's experience.
    Han HJ; Chu YC; Wang J; Lai YC; Tseng LM; Huang CC
    BMC Womens Health; 2023 Jun; 23(1):330. PubMed ID: 37344800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alcohol, Physical Activity, Smoking, and Breast Cancer Subtypes in a Large, Nested Case-Control Study from the Norwegian Breast Cancer Screening Program.
    Ellingjord-Dale M; Vos L; Hjerkind KV; Hjartåker A; Russnes HG; Tretli S; Hofvind S; Dos-Santos-Silva I; Ursin G
    Cancer Epidemiol Biomarkers Prev; 2017 Dec; 26(12):1736-1744. PubMed ID: 28877889
    [No Abstract]   [Full Text] [Related]  

  • 40. Overdiagnosis in the population-based organized breast cancer screening program estimated by a non-homogeneous multi-state model: a cohort study using individual data with long-term follow-up.
    Wu WY; Törnberg S; Elfström KM; Liu X; Nyström L; Jonsson H
    Breast Cancer Res; 2018 Dec; 20(1):153. PubMed ID: 30558679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.